Surely you understand that there is no way that Peter Rowland can be objective about EMV. For him to say anything positive about EMV's tech would be like Woolies CEO recommending his/her shareholders shop at Coles.
Perhaps ask yourself more meaningful questions like 1. Why have 3 leading hospitals undertaken to commence pivotal trials with EMV's device and 2. Why have 2 global leaders in stroke - Professors Davis and Donnan joined EMV's Advisory Board and 3. Why have leading neurologists and physicians such as Professor Stuart Crozier and David Cook acquired shares in EMV. That's a start, but there are many other leads you could follow rather than the predictable biased views of Peter Rowland!
EMvision Research Notes, page-1626
-
- There are more pages in this discussion • 1,093 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.000(0.00%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.06 | $2.00 | $59.88K | 29.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 4830 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |